Wako Pure Chemical to Market GNI's Pathway Software in Japan | GenomeWeb
NEW YORK (GenomeWeb News) – GNI, a drug-discovery firm based in Tokyo, has tapped Wako Pure Chemical to market its biopathway imaging and modeling software in Japan, GNI said last week.
 
Beginning in April, Wako will sell GNI’s Cell Illustrator software through its partner agencies in Japan.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.